Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T	Metastatic Castration-Resistant Prostate Cancer (mCRPC)	Recruiting	Phase 2	2025-08-27		NCT06134232

3 results · Page 1 of 1

Swipe the table sideways for more columns.

31 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Advanced Urology Associates	New Lenox	United States	1
Advanced Urology Institute	Daytona Beach	United States	10
Advanced Urology Institute	Largo	United States	3
Advanced Urology Institute	Ocala	United States	1
Arizona Urology Specialists	Tuscon	United States	1
Associated Medical Professionals of NY	Syracuse	United States	8
Associated Urological Specialists	Chicago Ridge	United States	9
Associated Urologists of North Carolina	Raleigh	United States	7
Carolina Urologic Research Center, LLC	Myrtle Beach	United States	15
Central Ohio Urology Group	Gahanna	United States	14
Chesapeake Urology Research Associates	Towson	United States	11
City of Hope - National Medical Center	Duarte	United States	1
Colorado Urology	Lakewood	United States	3
First Urology	Jeffersonville	United States	9
Florida Urology Partners	Riverview	United States	3
Integrated Medical Professionals	North Hills	United States	1
Keystone Urology Specialists	Lancaster	United States	11
Lowcountry Urology Institute	Charleston	United States	1
Michigan Institute of Urology	Troy	United States	14
MidLantic Urology	Bala-Cynwyd	United States	27
Oregon Urology Institute	Springfield	United States	14
Specialty Clinical Research of St. Louis	St Louis	United States	9
Spokane Urology	Spokane	United States	11
The Urology Group	Cincinnati	United States	9
Unio Health Partners - Genesis Research, LLC	San Diego	United States	1

Clinical trials